These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 29391125)

  • 1. Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases.
    Zerr I; Schmitz M; Karch A; Villar-Piqué A; Kanata E; Golanska E; Díaz-Lucena D; Karsanidou A; Hermann P; Knipper T; Goebel S; Varges D; Sklaviadis T; Sikorska B; Liberski PP; Santana I; Ferrer I; Zetterberg H; Blennow K; Calero O; Calero M; Ladogana A; Sánchez-Valle R; Baldeiras I; Llorens F
    Alzheimers Dement; 2018 Jun; 14(6):751-763. PubMed ID: 29391125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.
    Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P
    Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease.
    Zerr I; Villar-Piqué A; Hermann P; Schmitz M; Varges D; Ferrer I; Riggert J; Zetterberg H; Blennow K; Llorens F
    Alzheimers Res Ther; 2021 Apr; 13(1):86. PubMed ID: 33883011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between plasma and cerebrospinal fluid biomarkers for the early diagnosis and association with survival in prion disease.
    Abu-Rumeileh S; Baiardi S; Ladogana A; Zenesini C; Bartoletti-Stella A; Poleggi A; Mammana A; Polischi B; Pocchiari M; Capellari S; Parchi P
    J Neurol Neurosurg Psychiatry; 2020 Nov; 91(11):1181-1188. PubMed ID: 32928934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease.
    Kanata E; Golanska E; Villar-Piqué A; Karsanidou A; Dafou D; Xanthopoulos K; Schmitz M; Ferrer I; Karch A; Sikorska B; Liberski PP; Sklaviadis T; Zerr I; Llorens F
    J Clin Neurosci; 2019 Feb; 60():124-127. PubMed ID: 30309804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia.
    Llorens F; Schmitz M; Karch A; Cramm M; Lange P; Gherib K; Varges D; Schmidt C; Zerr I; Stoeck K
    Alzheimers Dement; 2016 May; 12(5):577-89. PubMed ID: 26718584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases.
    Llorens F; Villar-Piqué A; Schmitz M; Diaz-Lucena D; Wohlhage M; Hermann P; Goebel S; Schmidt I; Glatzel M; Hauw JJ; Sikorska B; Liberski PP; Riggert J; Ferrer I; Zerr I
    Neuropathol Appl Neurobiol; 2020 Apr; 46(3):240-254. PubMed ID: 31216593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic and Prognostic Value of Plasma GFAP in Sporadic Creutzfeldt-Jakob Disease in the Clinical Setting of Rapidly Progressive Dementia.
    Bentivenga GM; Baiardi S; Mastrangelo A; Zenesini C; Mammana A; Rossi M; Polischi B; Capellari S; Parchi P
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.
    Blennow K; Diaz-Lucena D; Zetterberg H; Villar-Pique A; Karch A; Vidal E; Hermann P; Schmitz M; Ferrer Abizanda I; Zerr I; Llorens F
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):846-853. PubMed ID: 31097472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia.
    Karch A; Llorens F; Schmitz M; Arora AS; Zafar S; Lange P; Schmidt C; Zerr I
    J Alzheimers Dis; 2016 Oct; 54(4):1385-1393. PubMed ID: 27589519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's Disease.
    Hermann P; Haller P; Goebel S; Bunck T; Schmidt C; Wiltfang J; Zerr I
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings.
    Eratne D; Loi SM; Li QX; Stehmann C; Malpas CB; Santillo A; Janelidze S; Cadwallader C; Walia N; Ney B; Lewis V; Senesi M; Fowler C; McGlade A; Varghese S; Ravanfar P; Kelso W; Farrand S; Keem M; Kang M; Goh AMY; Dhiman K; Gupta V; Watson R; Yassi N; Kaylor-Hughes C; Kanaan R; Perucca P; Dobson H; Vivash L; Ali R; O'Brien TJ; Hansson O; Zetterberg H; Blennow K; Walterfang M; Masters CL; Berkovic SF; Collins S; Velakoulis D;
    Alzheimers Dement; 2022 Nov; 18(11):2218-2233. PubMed ID: 35102694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CSF Ubiquitin Levels Are Higher in Alzheimer's Disease than in Frontotemporal Dementia and Reflect the Molecular Subtype in Prion Disease.
    Abu-Rumeileh S; Oeckl P; Baiardi S; Halbgebauer S; Steinacker P; Capellari S; Otto M; Parchi P
    Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32218217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
    Skillbäck T; Farahmand BY; Rosén C; Mattsson N; Nägga K; Kilander L; Religa D; Wimo A; Winblad B; Schott JM; Blennow K; Eriksdotter M; Zetterberg H
    Brain; 2015 Sep; 138(Pt 9):2716-31. PubMed ID: 26133663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients.
    Zerr I; Villar-Piqué A; Schmitz VE; Poleggi A; Pocchiari M; Sánchez-Valle R; Calero M; Calero O; Baldeiras I; Santana I; Kovacs GG; Llorens F; Schmitz M
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31795176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.
    Grangeon L; Paquet C; Bombois S; Quillard-Muraine M; Martinaud O; Bourre B; Lefaucheur R; Nicolas G; Dumurgier J; Gerardin E; Jan M; Laplanche JL; Peoc'h K; Hugon J; Pasquier F; Maltête D; Hannequin D; Wallon D;
    J Alzheimers Dis; 2016; 51(3):905-13. PubMed ID: 26890785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
    Riemenschneider M; Wagenpfeil S; Vanderstichele H; Otto M; Wiltfang J; Kretzschmar H; Vanmechelen E; Förstl H; Kurz A
    Mol Psychiatry; 2003 Mar; 8(3):343-7. PubMed ID: 12660807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.
    Stoeck K; Sanchez-Juan P; Gawinecka J; Green A; Ladogana A; Pocchiari M; Sanchez-Valle R; Mitrova E; Sklaviadis T; Kulczycki J; Slivarichova D; Saiz A; Calero M; Knight R; Aguzzi A; Laplanche JL; Peoc'h K; Schelzke G; Karch A; van Duijn CM; Zerr I
    Brain; 2012 Oct; 135(Pt 10):3051-61. PubMed ID: 23012332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
    Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.